Key Insights

Highlights

Success Rate

87% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

7.4%

4 terminated out of 54 trials

Success Rate

87.1%

+0.6% vs benchmark

Late-Stage Pipeline

6%

3 trials in Phase 3/4

Results Transparency

30%

8 of 27 completed with results

Key Signals

8 with results87% success

Data Visualizations

Phase Distribution

40Total
Not Applicable (22)
Early P 1 (1)
P 1 (7)
P 2 (7)
P 3 (2)
P 4 (1)

Trial Status

Completed27
Recruiting7
Unknown7
Withdrawn5
Terminated4
Active Not Recruiting2

Trial Success Rate

87.1%

Benchmark: 86.5%

Based on 27 completed trials

Clinical Trials (54)

Showing 20 of 20 trials
NCT06753136Not ApplicableRecruiting

Electrochemotherapy (ECT) in Patients With Primary Visceral Tumors and/or Secondary Visceral Localizations, of Any Histotype

NCT07241585Not ApplicableNot Yet RecruitingPrimary

Vitamin D Effects on Immune Microenvironment of Nonmelanoma Skin Cancer After Photodynamic Therapy (PDT)

NCT07434323Not ApplicableCompleted

Lavender Aromatherapy for Preoperative Anxiety in Melanoma and Epithelioma Patients

NCT07410676Phase 1Recruiting

EBNK-001 Allogeneic NK Cells With Low-Dose IL-15 ± Pembrolizumab in Advanced Solid Tumors

NCT02636569Phase 2CompletedPrimary

Topical Chemoprevention of Skin Cancer Biomarkers

NCT04091022Phase 2CompletedPrimary

Topical Diclofenac and Topical DFMO Chemoprevention Trial in Subjects With a History of Skin Cancer

NCT06384053Not ApplicableRecruiting

Skin Cancer and Hyperthermia and Radiotherapy

NCT05108090Not ApplicableRecruiting

Sentinel Lymph Node Biopsy for Cutaneous Squamous Cell Carcinoma of the Head and Neck

NCT05135052Not ApplicableActive Not RecruitingPrimary

Rhenium-Skin Cancer Therapy (SCT) for the Treatment of Non-Melanoma Skin Cancer.

NCT03906253Not ApplicableRecruiting

Effectiveness of Fractionated Laser Resurfacing to Protect Geriatric Skin From Actinic Neoplasia

NCT05955924Phase 3RecruitingPrimary

Nicotinamide Chemoprevention for Keratinocyte Carcinoma in Solid Organ Transplant Recipients - Pivotal Trial

NCT03024866CompletedPrimary

Comparison of eBX and Mohs Surgery for Treatment of Early-stage Non-melanoma Skin Cancer a Matched Pair Cohort Study.

NCT04969419Completed

Incidence of Melanoma and Non-melanoma Skin Cancer in People With Vitiligo

NCT05257486CompletedPrimary

Post-market Multi-Center RETRO-Prospective Study to Assess Long-term Clinical Outcomes NMSC Patients Treated With eBx

NCT05878288Phase 2Active Not Recruiting

Deep sequencIng in Cutaneous Squamous CEll caRciNomas

NCT04334824CompletedPrimary

Hydrochlorothiazide and Risk of Skin Cancer

NCT03327064Phase 1WithdrawnPrimary

A Biomarker Evaluation Trial of UAB30 in Renal Transplant Recipients at High Risk for Non-melanoma Skin Cancer

NCT06523816Not Yet RecruitingPrimary

Dermoscopy and Histopathology in Non-melanocytic Skin Tumors

NCT06428721Not ApplicableRecruiting

The Preventive Role of Fractionated Laser Resurfacing Against Actinic Neoplasia in an At-Risk Geriatric Population

NCT03110159Phase 1Completed

DUSA: Cyclic PDT for the Prevention of AK & NMSC in Solid Organ Transplant Recipients

Scroll to load more

Research Network

Activity Timeline